Systemic Amyloidosis: A Clinical Challenge from the Palliative Care Perspective.
Amyloidosis is a rare disease characterized by the extracellular deposition of misfolded amyloid proteins in various organs and tissues, leading to progressive organ dysfunction. The findings suggest that a patient-centered interdisciplinary approach enables more effective management of pain, dyspnea, fatigue, and other associated symptoms, in addition to enhancing emotional well-being and facilitating advance care planning.
Amyloidosis is a rare disease characterized by the extracellular deposition of misfolded amyloid proteins in various organs and tissues, leading to progressive organ dysfunction. The findings suggest that a patient-centered interdisciplinary approach enables more effective management of pain, dyspnea, fatigue, and other associated symptoms, in addition to enhancing emotional well-being and facilitating advance care planning.
What the study was
- Study design
- Review
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Journal of pain & palliative care pharmacotherapy
Why it surfaced
Low-signal Rare diseases with high unmet need entry (high-unmet-need population coverage); retained for topic coverage completeness.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.